Get the Stockscreener App
167.10
2.00%
-3.41
After Hours:
167.10
Charles River Laboratories International Inc Stock (CRL) Latest News
Charles River partners with SGH for cancer cell therapy services By Investing.com - Investing.com Canada
Charles River partners with SGH for cancer cell therapy services - Investing.com
Can Charles River's New Cell Banking Deal Transform Cancer Treatment Development? - StockTitan
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN
Insider Sell: Joseph Laplume Sells 4,400 Shares of Charles River Laboratories International Inc (CRL) - GuruFocus.com
Deciphering Charles River (CRL) International Revenue Trends - Nasdaq
Chairman of Charles River Laboratories International James Foster Buys 2.5% More Shares - Simply Wall St
TD Cowen Adjusts Price Target on Charles River Laboratories International to $179 From $182, Keeps Hold Rating - Marketscreener.com
Insider Buying: Birgit Girshick Acquires Shares of Charles River Laboratories International Inc (CRL) - GuruFocus.com
Charles River Laboratories International, Inc. (CRL) Executives Make Significant Stock Purchases - GuruFocus.com
Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call Transcript - MSN
Charles River Laboratories executive buys $249k in common stock By Investing.com - Investing.com South Africa
Charles River Laboratories targets $9.10-$9.60 EPS in 2025 amid cost optimization efforts - MSN
Charles River Executives Buy Company Stock Amidst Plan Terminations By Investing.com - Investing.com South Africa
William Blair cuts Charles River Labs stock rating to Market Perform - MSN
Charles River Laboratories executive sells shares worth $715,000 By Investing.com - Investing.com Australia
Charles River Executives Buy Company Stock Amidst Plan Terminations - Investing.com India
Charles River Laboratories executive sells shares worth $715,000 - Investing.com India
Charles River Laboratories executive buys $249k in common stock - Investing.com
Recent Transactions by Executives at Charles River Laboratories - TradingView
Charles River Laboratories International (NYSE:CRL) Price Target Cut to $173.00 by Analysts at Robert W. Baird - MarketBeat
Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Layoff Tracker: Spotlight Goes Dark After Disappointing Preclinical Data for CRISPR Platform - BioSpace
New York State Teachers Retirement System Cuts Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Empower Advisory Group LLC Acquires 6,747 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International, Inc. (NYSE:CRL) Short Interest Down 7.4% in January - MarketBeat
Vontobel Holding Ltd. Acquires Shares of 1,817 Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River Laboratories International (NYSE:CRL) Issues FY25 Earnings Guidance - MarketBeat
Stephens Cuts Charles River Laboratories International Price Target to $190 From $240 - Marketscreener.com
Charles River Labs makes good on promise to reduce headcount - The Business Journals
Charles River Laboratories International (NYSE:CRL) Shares Gap Up on Earnings Beat - MarketBeat
Charles River Laboratories International (NYSE:CRL) Posts Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
Charles River Laboratories International (NYSE:CRL) Issues FY 2025 Earnings Guidance - MarketBeat
Deutsche Bank Adjusts Charles River Laboratories International Price Target to $210 From $215, Maintains Buy Rating - Marketscreener.com
JPMorgan Adjusts Price Target on Charles River Laboratories International to $165 From $175, Maintains Neutral Rating - Marketscreener.com
Bryn Mawr Capital Management LLC Acquires 33,850 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Charles River: Q4 Earnings Snapshot - The Pioneer
Charles River Laboratories International Inc (CRL) Q4 2024 Earni - GuruFocus.com
Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance
Charles River Laboratories Faces Uncertainty in Achieving Cost Savings from Restructuring Efforts - TipRanks
Charles River Laboratories Reports 2024 Earnings and 2025 Outlook - TipRanks
Charles River Labs stock target cut to $175 by Evercore ISI - Investing.com South Africa
CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall - MSN
Charles River Labs: Mixed Signals in Earnings Call - TipRanks
Charles River Earnings: Near-Term Macroeconomic Challenges Affect Sales; Positive Long-Term Outlook - Morningstar
Charles River Labs Investor Failed to Depict Fraud, Company Says - Bloomberg Law
Narrow-Moat Charles River Faces Macroeconomic Pressures in Near Term; Positive Long-Term Outlook - Morningstar
Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance - Yahoo Finance
Q4 Earnings Surpass Expectations For The Andersons And Charles River Laboratories - Evrim Ağacı
1.50%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):